Elevate Your
Daily Routine.
Start free today. Backed by Neuroscience.
Free trial · Cancel anytime
Relax · Clinical Study
66 adolescent and young-adult females (ages 13–25) in residential eating disorder program received 24-minute Meditation & Energy Balance Quantum Harmonic audio therapy sessions in group settings. Each subject completed a Symptom Intensity Scale form documenting symptom levels prior to and immediately following each session.
40–54% symptom decrease per session across all measured symptoms
48% mean decrease across all symptoms from start to end of session
Largest reductions in moodiness (54.1%) and anger (53.6%)
Initial session showed 41–56% improvement across seven key categories
Evidence of learned symptom management across multiple sessions
Pre-session symptoms lowered from session to session in 6 out of 7 categories
Theracoustic Quantum Harmonics audio therapies provided significant reductions in self-reported symptom levels across the spectrum of emotional symptoms including stress, anxiety, fearfulness, anger, depression, moodiness and tension, demonstrating merit as adjunctive treatment.
While reporting generally heightened adverse emotional symptom levels prior to treatment sessions, patients reported significantly lower symptom levels post-sessions in this study conducted at The Renfrew Center.
Subjects received one of the 24-minute Meditation & Energy Balance Quantum Harmonic audio therapy sessions using the multiuser ThetaPlex audio player system, delivered in standard group sessions. Sixty-six adolescent and young-adult females aged 13–25 in a residential eating disorder program participated.
Key symptoms tracked included: stress, anxiety, fearfulness, anger, depression, moodiness, and tension.
Over all sessions, symptoms decreased 40–54% depending on symptom in each 24-minute audio therapy session. The mean across all symptoms was a 48% decrease from start to end of any session. The decrease in moodiness and anger were the largest, at over 50% per session.
For a patient's initial session, the average pre- to post-session improvement averaged 41% to 56% across the seven key categories — higher overall than subsequent sessions, with evidence that subjects are learning to manage their symptoms from session to session. From session to session, tracked symptoms lowered in six out of seven categories.
Research disclosure. The studies referenced on this page were conducted under Theracoustic™, a trading name of the same company and team behind WellAudio, using the same underlying audio therapy technology and methodology. WellAudio is a new consumer product built on this foundation. These studies were carried out prior to the launch of WellAudio and were not performed using this application specifically. Results reflect outcomes from clinical and institutional settings and may not be representative of individual consumer use.
Answers to common questions about WellAudio
and your listening experience.